Read More Pharma Industry News Atai Life Sciences stock jumps 15% after Beckley Psytech trial update deepens investor interest in BPL-003 Atai Life Sciences stock surged 15% after positive BPL-003 trial data with Beckley Psytech. Investors eye Phase 3 momentum and merger milestones. byPallavi MadhirajuSeptember 23, 2025